Tadahiro Matsushita
Tadahiro Matsushita publishes mostly in Molecular Biology, Pharmacology and Molecular Medicine, on topics such as Antibiotics Pharmacokinetics and Efficacy, Antibiotic Resistance in Bacteria and Cancer therapeutics and mechanisms.
- World rank
- #6,983,988 of 7,710,434 ranked researchers
- Rank in United States
- #1,573,369 of 1,627,098
- Works
- 18
- Citations
- 191
- Citations per work
- 10.6
What does Tadahiro Matsushita research?
Tadahiro Matsushita's work is mostly in Medicine (39%), Biochemistry, Genetics and Molecular Biology (37%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Health Sciences739.3%
- Medicine739.3%
- Life Sciences737.3%
- Everything else423.4%
- 1Molecular Biology26% of their works
- 2Pharmacology22% of their works
- 3Molecular Medicine12% of their works
- 4Infectious Diseases6% of their works
- 5Surgery6% of their works
- 6Epidemiology6% of their works
Research topics
- Antibiotics Pharmacokinetics and Efficacy
- Antibiotic Resistance in Bacteria
- Cancer therapeutics and mechanisms
- Pneumonia and Respiratory Infections
- Microbial Natural Products and Biosynthesis
- Biochemical and Structural Characterization
- Gastric Cancer Management and Outcomes
- Helicobacter pylori-related gastroenterology studies
Which keywords describe Tadahiro Matsushita's research?
The keywords of their largest research topics: Antimicrobial Resistance, Antibiotic Pharmacokinetics, Antibiotic Resistance, Critically Ill Patients, Chemotherapy, ESKAPE Pathogens, Multidrug-Resistant Bacteria and Clinical Practice Guidelines.
- Molecular Characterization
- Helicobacter pylori
- Cyclotides
- Natural Products
- Community-Acquired Pneumonia
- Topoisomerases
- Clinical Practice Guidelines
- ESKAPE Pathogens
- Critically Ill Patients
- Antibiotic Pharmacokinetics
- Antimicrobial Resistance
- Antibiotic Resistance
- Chemotherapy
- Multidrug-Resistant Bacteria
- DNA
- Gastric Cancer
- Drug Discovery
- Pneumococcal Conjugate Vaccine
- Endoscopic Resection
- Inflammation
- Sortase
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 21 words, with their numbers
- Antimicrobial Resistance112 topics
- Antibiotic Pharmacokinetics81 topic
- Antibiotic Resistance82 topics
- Critically Ill Patients81 topic
- Chemotherapy72 topics
- ESKAPE Pathogens61 topic
- Multidrug-Resistant Bacteria61 topic
- Clinical Practice Guidelines52 topics
- DNA51 topic
- Topoisomerases51 topic
- Gastric Cancer42 topics
- Community-Acquired Pneumonia31 topic
- Drug Discovery31 topic
- Natural Products31 topic
- Pneumococcal Conjugate Vaccine31 topic
- Cyclotides21 topic
- Endoscopic Resection21 topic
- Helicobacter pylori21 topic
- Inflammation21 topic
- Molecular Characterization21 topic
- Sortase21 topic
Where does Tadahiro Matsushita work?
Tadahiro Matsushita's main affiliation in the publication record is Tanabe Research Laboratories, United States.
How many publications and citations does Tadahiro Matsushita have?
OpenAlex counts 18 works and 191 citations for Tadahiro Matsushita, an h-index of 8, ranking #6,983,988 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Tadahiro Matsushita. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.